From October 28, 2021 to February 10, 2022, the company has repurchased 883,300 shares, representing 1.13% for ¥7,999.54 million. With this, the company has completed the repurchase of 883,300 shares, representing 1.13% for ¥7,999.54 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,543 JPY | -0.66% | +0.71% | -18.37% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.37% | 2.61B | |
+8.74% | 129B | |
+14.18% | 74.67B | |
-16.39% | 62.59B | |
+0.82% | 52.86B | |
-12.40% | 36.11B | |
+3.68% | 33.57B | |
+9.28% | 17.29B | |
+7.68% | 14.75B | |
-9.06% | 10.82B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.